Papers/PMID:27329332
A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control.
Pharmacological research2016The record
1 finding · 1 compound · 1 endpoint · 1 null
What it reported
How to read these marksEvery finding here is a null result.
What did not
1 finding
magnesium(2+) — no detected effect on glycated haemoglobin (HbA1c)
Evidence strength: very limited.FindingNull result“A significant effect of magnesium supplementation was observed on HOMA-IR index (WMD: -0.67, 95% CI: -1.20, -0.14, p=0.013) but not on plasma glucose (WMD: -0.20mmol/L, 95% CI: -0.45, 0.05, p=0.119), HbA1c (WMD: 0.018mmol/L, 95% CI: -0.10, 0.13, p=0.756), and insulin (WMD: -2.22mmol/L, 95% CI: -9.62, 5.17, p=0.556).”
Quoted verbatim from A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control.. - Study
- meta-analysis
- Population
- Diabetic and non-diabetic individuals in randomised trials of oral magnesium supplementation
Effect 0.018 mean difference, 95% CI -0.1 to 0.13
A systematic review and meta-analysis of randomized controlled trials on the effects of magnesium supplementation on insulin sensitivity and glucose control.2016PMID:2732933210.1016/j.phrs.2016.06.019Permalink